Skip to main content
. 2015 Oct 29;7(3):3599–3613. doi: 10.18632/oncotarget.6120

Figure 5. Chemotherapy response and mutation status of NOTCH1 and PIK3CA.

Figure 5

A. Left panel: The frequencies of the patients who exhibited sensitivity to standard chemotherapy are described in three groups: patients with NOTCH1 mutations, PIK3CA mutations, or patients with neither, in cohort #1. Right panel: chi-square test with Bonferroni correction was used to compare the chemotherapeutic efficacy of the subgroups in cohort #1. B. PFS of 29 patients with NOTCH1 or PIK3CA mutations in cohort #1. C. Cox regression analysis was used to examine the PFS.